73020 Federal Register / Vol. 88, No. 204 / Tuesday, October 24, 2023 / Notices 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–23459 Filed 10–23–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to 5 U.S.C section 1009(d), 

notice is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended, and the Determination of 

the Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, CDC, pursuant to Public Law 

92–463. The grant applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

CE24–034, Rigorous Evaluation of 

Policies for their Impacts on the Primary 

Prevention of Multiple Forms of 

Violence. 

Date: February 27, 2024. 

Time: 8 a.m.–5 p.m., EST. 

Place: Web Conference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Carlisha Gentles, PharmD, BCPS, 

CDCES, Scientific Review Officer, 

National Center for Injury Prevention 

and Control, CDC, 4770 Buford Highway 

NE, Mailstop F–63, Atlanta, Georgia 

30341, Telephone: (770)488–1504; 

Email: CGentles@cdc.gov. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–23458 Filed 10–23–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, Deputy 

Director for Infectious Diseases 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with regulatory 

provisions, the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

Board of Scientific Counselors, Deputy 

Director for Infectious Diseases (BSC, 

DDID). This virtual meeting is open to 

the public via Zoom, limited only by the 

number of web conference lines 

available (500 lines). Registration in 

advance is required by accessing the 

link below in the addresses section. 

Time will be available for public 

comment. 

DATES: The meeting will be held on 

November 30, 2023, from 1:30 p.m. to 3 

p.m., EST. 

ADDRESSES: Zoom virtual meeting. 

Registration in advance is required by 

accessing the link at https://

cdc.zoomgov.com/webinar/register/WN_

_r2EU3xBTB6MBiQq_HdqNQ. 

Instructions to access the meeting will 

be provided following registration. 

FOR FURTHER INFORMATION CONTACT: 

Sarah Wiley, MPH, Senior Advisor, 

National Center for Emerging and 

Zoonotic Infectious Diseases, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, Mailstop H16–5, 

Atlanta, Georgia 30329–4037. 

Telephone: (404) 639–4840; Email: 

SWiley@cdc.gov. 

SUPPLEMENTARY INFORMATION: Purpose: 

The Board of Scientific Counselors, 

Deputy Director for Infectious Diseases 

(BSC, DDID) provides advice and 

guidance to the Secretary, Department 

of Health and Human Services; the 

Director, Centers for Disease Control 

and Prevention (CDC); and the Directors 

of the National Center for Emerging and 

Zoonotic Infectious Diseases, the 

National Center for HIV, Viral Hepatitis, 

STD, and TB Prevention, the National 

Center for Immunization and 

Respiratory Diseases, concerning 

strategies, goals, and priorities for the 

programs and research within the 

national centers and monitors the 

overall strategic direction and focus of 

CDC’s infectious disease programs and 

centers. 

Matters To Be Considered: The agenda 

will include updates and discussions on 

recent outbreaks and disease 

surveillance strategies, as well as a brief 

report from one of the Board’s 

workgroups: the Food Safety 

Modernization Act Surveillance 

Working Group. Agenda items are 

subject to change as priorities dictate. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–23460 Filed 10–23–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 5 U.S.C. 

Section1009(d), notice is hereby given 

of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, CDC, pursuant to Public Law 

92–463. The grant applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 204 / Tuesday, October 24, 2023 / Notices 73021 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

CE24–011, Grants to Support New 

Investigators in Conducting Research 

Related to Understanding Drug Use and 

Overdose Risk and Protective Factors 

(K01). 

Date: March 5, 2024. 

Time: 8:30 a.m.–5 p.m., EST. 

Place: Web Conference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Aisha L. Wilkes, M.P.H., Scientific 

Review Officer, National Center for 

Injury Prevention and Control, Centers 

for Disease Control and Prevention, 

4770 Buford Highway NE, Mailstop 

S106–9, Atlanta, Georgia 30341, 

Telephone: (404) 639–6473; Email: 

AWilkes@cdc.gov. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–23457 Filed 10–23–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Title IV–E Prevention Services 

Clearinghouse Handbook of Standards 

and Procedures, Draft Version 2.0 

AGENCY: Administration for Children 

and Families, Department of Health and 

Human Services. 

ACTION: Request for public comment. 

SUMMARY: The Administration for 

Children and Families (ACF), within the 

U.S. Department of Health and Human 

Services (HHS), oversees the Title IV–E 

Prevention Services Clearinghouse. ACF 

seeks comments on proposed changes 

and clarifications to existing standards 

and procedures in the Handbook of 

Standards and Procedures, Version 2.0. 

DATES: The deadline for comments on 

this notice is November 24, 2023. 

ADDRESSES: Interested parties may 

submit written questions, comments, 

and supplementary documents by email 

to preventionservices@abtassoc.com 

with ‘‘Title IV–E Prevention Services 

Clearinghouse FRN comment’’ in the 

subject line. To ensure that your 

comments have maximum effect, please 

identify clearly the section of the draft 

Handbook of Standards and Procedures, 

Version 2.0 that your comments 

address. 

Readers are referred to the full version 

of the draft Handbook of Standards and 

Procedures, Version 2.0 on the 

Clearinghouse website (https://

preventionservices.acf.hhs.gov/ 

resources/comment-draft-handbook). 

SUPPLEMENTARY INFORMATION: 

1.0 Background and Legislative 

Context 

The Family First Prevention Services 

Act (FFPSA) was signed into law as part 

of the Bipartisan Budget Act (H.R. 1892) 

on February 9, 2018. FFPSA amended 

the Social Security Act (the Act) to 

enable use of Federal funds available 

under parts B and E of title IV of the 

Social Security Act to provide enhanced 

support to children and families and 

prevent foster care placements through 

the provision of evidence-based ‘‘mental 

health and substance abuse prevention 

and treatment services, in-home parent 

skill-based programs, and kinship 

navigator services.’’ As described in the 

statutory language, these services and 

programs are intended ‘‘for children 

who are candidates for foster care or 

who are pregnant or parenting foster 

youth and the parents or kin caregivers 

of the children.’’ The Act requires an 

independent systematic review of 

evidence to designate programs and 

services as ‘‘promising,’’ ‘‘supported,’’ 

and ‘‘well-supported’’ practices. 

In order to meet these requirements, 

ACF established the Title IV–E 

Prevention Services Clearinghouse (the 

Clearinghouse). The Clearinghouse 

carries out a systematic review process 

implemented by trained reviewers using 

consistent, transparent standards and 

procedures. The Handbook of Standards 

and Procedures, Version 1.0 (https://

preventionservices.acf.hhs.gov/reviewprocess) provides a detailed description 

of the standards used to identify and 

review programs and services for the 

Clearinghouse and the procedures 

followed by the Clearinghouse staff. The 

Handbook of Standards and Procedures, 

Version 1.0 was informed by public 

comments submitted in response to 

Federal Register Notice 83 FR 29122 

(https://www.federalregister.gov/ 

documents/2018/06/22/2018-13420/ 

decisions-related-to-the-development-ofa-clearinghouse-of-evidence-basedpractices-in-accordance), consultations 

with research and practice experts, and 

the review processes developed and 

used by other prominent evidence 

clearinghouses. 

2.0 Overview of 2021 Request for 

Public Comment on Title IV–E 

Prevention Services Clearinghouse 

Handbook of Standards and 

Procedures, Version 1.0 

ACF solicited feedback on the 

Prevention Services Clearinghouse 

Handbook of Standards and Procedures, 

Version 1.0 (subsequently referred to as 

Handbook Version 1.0) through a 

Federal Register Notice 86 FR 37332 

(https://www.federalregister.gov/ 

documents/2021/07/15/2021-15065/ 

title-iv-e-prevention-servicesclearinghouse-handbook-of-standardsand-procedures) published on July 15, 

2021. This comment period was open 

for 30 days and closed on August 16, 

2021. One hundred four unique 

commenters submitted feedback, 

including 10 commenters from state and 

local child welfare agencies. 

Commenters included state and local 

government administrators, program 

and service developers, Federal staff, 

researchers and evaluators, foundation 

and non-profit organization staff, and 

other interested parties. ACF ensured 

the careful review and consideration of 

all of the comments in developing the 

draft Handbook of Standards and 

Procedures, Version 2.0 (subsequently 

referred to as Handbook Version 2.0). 

Comments were considered within the 

context of the statutory requirements of 

FFSPA, the necessity to conduct a 

systematic, objective, and transparent 

evidence review, and resource 

considerations. The public comments 

informed discussions with a large 

number of experts whose comments 

were also considered in developing the 

proposed revisions. 

Summary of Comments. Comments 

highlighted how the standards and 

procedures specified in Handbook 

Version 1.0 might be revised to better 

reflect the goals and requirements of the 

Executive Order on Advancing Racial 

Equity and Support for Underserved 

Communities Through the Federal 

Government. For example, commenters 

recommended prioritizing the review of 

programs and services that have been 

implemented and/or studied with 

diverse populations (Section 2.2). 

Commenters also recommended 

engaging diverse individuals and those 

with lived experience to inform the 

systematic review process and allowing 

greater flexibility for culturally adapted 

programs and services. Commenters 


ddrumheller on DSK120RN23PROD with NOTICES1